Who Generates Higher Gross Profit? Zoetis Inc. or Bio-Techne Corporation

A Tale of Two Companies: Zoetis Inc. vs. Bio-Techne Corporation

In the competitive landscape of the pharmaceutical and biotechnology sectors, understanding who leads in gross profit can offer valuable insights. From 2014 to 2023, Zoetis Inc. consistently outperformed Bio-Techne Corporation in generating gross profit. Zoetis Inc. saw a remarkable increase of approximately 90% over this period, peaking in 2023 with a gross profit of over $5.8 billion. In contrast, Bio-Techne Corporation, while showing steady growth, reached its highest gross profit of around $770 million in 2023, marking a 206% increase since 2014.

This data highlights Zoetis Inc.'s dominant position, with its gross profit consistently being over six times that of Bio-Techne Corporation. However, Bio-Techne's impressive growth rate suggests a promising trajectory. As we look to the future, the absence of 2024 data for Zoetis Inc. leaves room for speculation on whether this trend will continue.